Obesity ups survival in heart failure, but that’s no reason to pile on pounds

(HealthDay)—Obese people with heart failure may live longer than those who are thinner—especially if they are “metabolically healthy,” a new […]
» Read morenohealthproblemsnews.com
(HealthDay)—Obese people with heart failure may live longer than those who are thinner—especially if they are “metabolically healthy,” a new […] An international study published in the journal Blood by researchers led by Dr. Elie Haddad, a pediatric immunologist and researcher […] FRIDAY, Oct. 26, 2018 — Overall, cancer survival among adolescents and young adults (AYAs) has consistently exceeded that of other […] MONDAY, Oct. 22, 2018 — For patients with metastatic triple-negative breast cancer, atezolizumab plus nanoparticle albumin-bound (nab)-paclitaxel prolongs progression-free survival […] Treating the prostate with radiotherapy alongside standard treatment led to an 11 per cent increase in survival for some men […] Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free […] A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma […] In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP […]
Obesity ups survival in heart failure, but that’s no reason to pile on pounds
Researchers finds better ways to improve the chances of survival of children with a rare immune deficiency
Cancer Survival Higher in Teens, Young Adults Than Other Groups
Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
Cancer trial shows treating the prostate with radiotherapy improves survival
Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
Brain cancer survival has improved – but not much for elderly
PARP inhibitor improves progression-free survival in patients with advanced breast cancers